盛通股份(002599.SZ)完成註銷48.926萬份股票期權
格隆匯12月11日丨盛通股份(002599.SZ)公佈,公司於2019年10月25日召開第四屆董事會2019年第九次會議,審議通過了《關於註銷部分已獲授但尚未行權的股票期權的議案》,因原激勵對象22人已離職,不再滿足成為激勵對象的條件,公司決定註銷其已獲授但未行權的股票期權48.926萬份。
近日,公司向中國證券登記結算有限責任公司深圳分公司提交了註銷上述48.926萬份股票期權的申請,涉及激勵對象22人。2019年12月11日,經中國證券登記結算有限公司深圳分公司審核確認,公司已完成上述股票期權的註銷事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.